Literature DB >> 19238492

A single-institution experience with eight CD117-positive primary extragastrointestinal stromal tumors: critical appraisal and a comparison with their gastrointestinal counterparts.

Brian K P Goh1, Pierce K H Chow, Sittampalam M Kesavan, Wai-Ming Yap, Yaw-Fui A Chung, Wai-Keong Wong.   

Abstract

INTRODUCTION: Gastrointestinal stromal tumors (GISTs) arising from outside the gut wall also termed extragastrointestinal stromal tumors (EGISTs) are reported to be rare. Presently, their pathogenesis remains controversial, and recently, it has been proposed that EGISTs may be the result of extensive extramural growth of GISTs which lose contact with the gut wall. This study presents a single-institution experience with eight EGISTs and compares their clinicopathological features with mural GISTs in order to determine further insight to their possible origin.
METHODS: Between 1997 and 2008, 156 patients with pathologically proven CD117-positive primary GISTs were retrospectively reviewed. Eight tumors were identified as EGISTs, 104 were gastric GISTs, and 44 were small-bowel GISTs. Mural GISTs were classified as extramural or intra/transmural according to their gross pattern of growth.
RESULTS: There were five male and three female patients with a median age of 58 years (range, 42-81 years). All patients were symptomatic, and the tumors were located in the greater omentum (n = 2), lesser sac (n = 2), lesser omentum, retroperitoneum, small-bowel mesentery, and pancreas. The median tumor size was 140 mm (range, 55 to 220 mm). Seven of eight EGISTs were found to be in close association to the adjacent gut wall. Pathological examination demonstrated that two tumors demonstrated focal involvement of the muscularis propria of the adjacent gut wall. Four tumors demonstrated tumor abutting or adherent to the serosa but no muscle involvement and one tumor was separated from the serosa. Comparison between the clinicopathological features of EGISTs with extramural GISTs and intra/transmural GISTs demonstrated that EGISTs were significantly larger [140 range (55-220) mm vs 80 (5-260) mm vs 50 (15-190) mm, P = 0.049, P < 0.001 respectively].
CONCLUSION: The occurrence of true EGISTs is rare. Most cases demonstrate some form of communication or contact with the gut wall, and EGISTs are significantly larger than extramural or intra/transmural GIST. These observations suggest that most, if not all, cases of EGISTs are likely to represent mural GISTs with extensive extramural growth with eventual loss of contact with the muscle layer of the gut.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238492     DOI: 10.1007/s11605-009-0828-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

1.  Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm.

Authors:  C Ortiz-Hidalgo; B de Leon Bojorge; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Gastrointestinal stromal tumor of the retroperitoneum: CT and MR findings.

Authors:  Hidemasa Takao; Ko Yamahira; Ippei Doi; Toshiaki Watanabe
Journal:  Eur Radiol       Date:  2004-08-05       Impact factor: 5.315

3.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

4.  Primary gastrointestinal stromal tumor in the retroperitoneum.

Authors:  Itsuhiro Takizawa; Hideo Morishita; Shingo Matsuki; Takeshi Komeyama; Iwao Emura; Noboru Hara
Journal:  Int J Urol       Date:  2006-09       Impact factor: 3.369

5.  Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate?

Authors:  Brian K P Goh; Pierce K H Chow; Sittampalam Kesavan; Wai-Ming Yap; Wai-Keong Wong
Journal:  J Surg Oncol       Date:  2008-04-01       Impact factor: 3.454

Review 6.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

7.  Primary malignant gastrointestinal stromal tumor of the liver.

Authors:  Xuejiao Hu; Jameson Forster; Ivan Damjanov
Journal:  Arch Pathol Lab Med       Date:  2003-12       Impact factor: 5.534

8.  Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.

Authors:  Brian K P Goh; Pierce K H Chow; Wai-Ming Yap; Sittampalam M Kesavan; In-Chin Song; Pradeep G Paul; Boon-Swee Ooi; Yaw-Fui A Chung; Wai-Keong Wong
Journal:  Ann Surg Oncol       Date:  2008-06-11       Impact factor: 5.344

9.  Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal.

Authors:  S Sakurai; T Fukasawa; J M Chong; A Tanaka; M Fukayama
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 10.  Malignant gastrointestinal stromal tumor of the gallbladder.

Authors:  Jong Kyung Park; Seung Hye Choi; Seong Lee; Ki Ouk Min; Sang Seob Yun; Hae Myung Jeon
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more
  20 in total

1.  Stomach GIST presenting as a liver abscess.

Authors:  Farhad Fakhrejahani; David Gemmel; Sudershan K Garg
Journal:  J Gastrointest Cancer       Date:  2014-12

2.  An atypically localized gastrointestinal stromal tumor: a case report of pancreas gastrointestinal stromal tumor.

Authors:  Kürşat Rahmi Serin; Metin Keskin; Mine Güllüoğlu; Ali Emre
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

3.  Extra Gastrointestinal Stromal Tumor treated with imatinib in a patient with Neurofibromatosis type 1.

Authors:  Akshiv Malhotra; Jonathan Wright; Ajeet Gajra
Journal:  J Gastrointest Oncol       Date:  2012-12

4.  Rare cases reports of gastrointestinal stromal tumour (GIST).

Authors:  M Amendolara; S Ramuscello; A Broggiato; A Andreotti; G Stevanato; M Bonfiglio; M Bernardi; D Parini; F Galeotti; M Rizzo
Journal:  G Chir       Date:  2014 May-Jun

Review 5.  Minimally invasive surgery for gastric gastrointestinal stromal tumors.

Authors:  Ye-Xin Koh; Brian K P Goh
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-12

6.  Pancreatic extragastrointestinal stromal tumor: A case report and comprehensive literature review.

Authors:  Sami Akbulut; Rıdvan Yavuz; Emrah Otan; Sinan Hatipoglu
Journal:  World J Gastrointest Surg       Date:  2014-09-27

7.  Gastrointestinal stromal tumor presenting as a hormonally inactive adrenal mass.

Authors:  Márta Sereg; István Buzogány; Gábor Gonda; Zoltán Sápi; Eva Csöregh; Zsuzsa Jakab; Károly Rácz; Miklós Tóth
Journal:  Endocrine       Date:  2011-02       Impact factor: 3.633

8.  Secondary recurrent multiple EGIST of the mesentary: A case report and review of the literature.

Authors:  Ilona D Goukassian; S R Kussman; Y Toribio; Jennifer E Rosen
Journal:  Int J Surg Case Rep       Date:  2012-04-05

9.  GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.

Authors:  Markku Miettinen; Anna Felisiak-Golabek; Zengfeng Wang; Shingo Inaguma; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2017-05       Impact factor: 6.394

Review 10.  Extragastrointestinal stromal tumors of the omentum: review apropos of a case with a novel gain-of-function KIT mutation.

Authors:  Georgia Dedemadi; George Georgoulis; Dimitrios Kontopanos; Evangelos Anagnostou; George Morphopoulos; Jean-François Emile; Constantinos Christopoulos
Journal:  J Gastrointest Cancer       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.